Hinge Health (HNGE) Gains from Sales and Divestitures (2025)
Hinge Health recorded quarterly Gains from Sales and Divestitures of $844426.0 in Q3 2025, up 178.11% quarter-over-quarter from $303634.0 in Q2 2025.
Hinge Health's Gains from Sales and Divestitures history runs 1 years deep, the most recent figure standing at $844426.0 for Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.29 Bn | 27.22 Bn | 1.98 Bn |
| 2 | Veeva Systems | 26.21 Bn | 19.65 Bn | 622.47 Mn |
| 3 | BrightSpring Health Services | 11.98 Bn | 11.10 Bn | 482.22 Mn |
| 4 | Healthequity | 7.59 Bn | 7.27 Bn | 228.15 Mn |
| 5 | Hinge Health | 4.34 Bn | 4.03 Bn | 154.23 Mn |
| 6 | Waystar Holding | 3.75 Bn | 3.59 Bn | 268.04 Mn |
| 7 | Doximity | 3.73 Bn | 2.98 Bn | 125.97 Mn |
| 8 | 10x Genomics | 3.04 Bn | 2.50 Bn | 106.18 Mn |
| 9 | Privia Health | 2.83 Bn | 2.46 Bn | 595.71 Mn |
| 10 | Omnicell | 2.01 Bn | 1.84 Bn | 140.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 844,426.00 |
| Sep 30, 2025 | 844,426.00 |
| Jun 30, 2025 | 303,634.00 |
| Jun 30, 2025 | 303,634.00 |